Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-113206
Filing Date
2024-10-07
Accepted
2024-10-07 16:05:09
Documents
21
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A onvo-20241004.htm   iXBRL DEF 14A 1458071
2 GRAPHIC img64670392_0.jpg GRAPHIC 5195
3 GRAPHIC img64670392_1.jpg GRAPHIC 2300
4 GRAPHIC img64670392_2.jpg GRAPHIC 2300
5 GRAPHIC img64670392_3.jpg GRAPHIC 2761
6 GRAPHIC img64670392_4.jpg GRAPHIC 161611
7 GRAPHIC img64670392_5.jpg GRAPHIC 162434
8 GRAPHIC img64670392_6.jpg GRAPHIC 2300
9 GRAPHIC img64670392_7.jpg GRAPHIC 96008
10 GRAPHIC img64670392_8.jpg GRAPHIC 342388
  Complete submission text file 0000950170-24-113206.txt   4062040

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onvo-20241004.xsd EX-101.SCH 7548
24 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20241004_htm.xml XML 234607
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-35996 | Film No.: 241357826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)